SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Time line

<< Previous

Bullboard Posts

Next >>

Comment by 25Stone7859on Mar 03, 2021 11:58am

85 Views

Post# 32705247

RE:Time line

Hey Begginer,
You are not reading the information correctly. The Corporate Deck timing refers to calendar years not fiscal years as in SQI's official financial reporting schedule. That means the submissions will be made in Q1 and Q2 as per the respective charts. Go to page fourteen of the Corporate Deck and notice the arrow bars and the work that still must be concluded before application can be submitted. Those arrows have probably lengthened by now. As for FDA EUA approval timing, remember there are scores of other companies involved in COVID-19 also looking to submit their proposals.
Oh yes, remember to watch your grammer...

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?